Louisiana 2010 2010 Regular Session

Louisiana House Bill HB121 Engrossed / Bill

                    HLS 10RS-733	ENGROSSED
Page 1 of 5
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
Regular Session, 2010
HOUSE BILL NO. 121
BY REPRESENTATIVE MILLS
CONTROLLED SUBSTANCES: Amends the composition of schedules for controlled
dangerous substances
AN ACT1
To amend and reenact R.S. 40:964(Schedule III)(E)(9), to enact R.S. 40:964(Schedule2
I)(C)(13.1), (16.1), (32), (33), (34), and (35), (Schedule II)(A)(1)(s), (B)(28), and3
(C)(7), (Schedule III)(E)(12.1), (15.1), and (44.1), (Schedule IV)(B)(4.1) and (22.1),4
and (Schedule V)(D)(2), and to repeal R.S. 40:964(Schedule IV)(B)(52), relative to5
the Uniform Controlled Dangerous Substances Law; to add certain drugs to6
Schedules I, II, III, IV, and V; to provide for technical changes; and to provide for7
related matters.8
Be it enacted by the Legislature of Louisiana:9
Section 1. R.S. 40:964(Schedule III)(E)(9) is hereby amended and reenacted and10
R.S. 40:964(Schedule I)(C)(13.1), (16.1), (32), (33), (34), and (35), (Schedule II)(A)(1)(s),11
(B)(28), and (C)(7), (Schedule III)(E)(12.1), (15.1), and (44.1), (Schedule IV)(B)(4.1) and12
(22.1), and (Schedule V)(D)(2) are hereby enacted to read as follows:13
ยง964.  Composition of schedules14
Schedules I, II, III, IV, and V shall, unless and until added to pursuant to R.S.15
40:962, consist of the following drugs or other substances, by whatever official16
name, common or usual name, chemical name, or brand name designated:17 HLS 10RS-733	ENGROSSED
HB NO. 121
Page 2 of 5
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
SCHEDULE I1
*          *          *2
C. Hallucinogenic substances.  Unless specifically excepted or unless listed3
in another schedule, any material, compound, mixture, or preparation, which4
contains any quantity of the following hallucinogenic substances, or which contains5
any of their salts, isomers, or salts of isomers, whenever the existence of such salts,6
isomers, or salts of isomers is possible within the specific chemical designation, for7
purposes of this Paragraph only, the term "isomer" includes the optical, position, and8
geometric isomers:9
*          *          *10
(13.1)  Alphamethyltryptamine11
*          *          *12
(16.1)  5-methoxy-N, N-diisopropyltryptamine13
*          *          *14
(32) 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol {also15
known as CP 47,497 and its C6, C7, C8, and C9 homologues}16
(33) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-17
6a,7,10,10a-tetrahydrobenzo [c]chromen-1-ol {also known as HU-210}18
(34) Naphthalen-1-yl-(1-pentylindol-3-yl)methanone {also known as 1-19
Pentyl-3-(1-naphthoyl)indole or JWH-018}20
(35) Naphthalen-1-yl-(1-butylindol-3-yl)methanone {also known as 1-Butyl-21
3-(1-naphthoyl)indole or JWH-073}22
*          *          *23
SCHEDULE II24
A. Substances of vegetable origin or chemical synthesis.  Unless specifically25
excepted or unless listed in another schedule, any of the following substances26
whether produced directly or indirectly by extraction from substances of vegetable27
origin, or independently by means of chemical synthesis, or by a combination of28
extraction and chemical synthesis:29 HLS 10RS-733	ENGROSSED
HB NO. 121
Page 3 of 5
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
(1) Opium and opiate, and any salt, compound, isomer, derivative, or1
preparation of opium or opiate, excluding apomorphine, thebaine-derived2
butorphanol, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone, and3
their respective salts, but including the following:4
*          *          *5
(s)  Oripavine6
*          *          *7
B. Opiates.  Unless specifically excepted or unless listed in another schedule,8
any of the following opiates, including its isomers, esters, ethers, salts, and salts of9
isomers, esters, ethers, and salts is possible within the specific chemical designation,10
dextrorphan and levopropoxyphene excepted:11
*          *          *12
(28)  Tapentadol13
C. Stimulants.  Unless specifically excepted or unless listed in another14
schedule, any material, compound, mixture, or preparation which contains any15
quantity of the following substances having a stimulant effect on the central nervous16
system:17
*          *          *18
(7)  Lisdexamfetamine, its salts, isomers, and salts of its isomers19
*          *          *20
SCHEDULE III21
*          *          *22
E. Anabolic steroids and muscle building substances.  Unless specifically23
excepted or unless listed in another schedule, any material, compound, mixture, or24
preparation, containing any quantity of the following substances, including its salts,25
esters, ethers, isomers, and salts of isomers whenever the existence of such salts,26
esters, ethers, isomers, and salts of isomers is possible within the specific chemical27
designation. The term "anabolic steroid" means any drug or hormonal substance,28
chemically and pharmacologically related to testosterone, other than estrogens,29 HLS 10RS-733	ENGROSSED
HB NO. 121
Page 4 of 5
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
progestins, corticosteroids, and dehydroepiandrosterone that promote muscle growth1
and include the following:2
*          *          *3
(9)  (Methandrostenolone) 4-androstenedione4
*          *          *5
(12.1)  Boldione6
*          *          *7
(15.1)  Desoxymethyltestosterone8
*          *          *9
(44.1)  19-nor-4, 9(10)-androstadienedione10
*          *          *11
SCHEDULE IV12
*          *          *13
B.  Depressants14
Unless specifically excepted or unless listed in another schedule, any15
material, compound, mixture, or preparation containing any quantity of the following16
substances, including its salts, isomers, and salts of isomers, whenever the existence17
of such salts, isomers, and salts of isomers is possible within the specific chemical18
designation:19
*          *          *20
(4.1)  Carisoprodol21
*          *          *22
(22.1)  Fospropofol23
*          *          *24
SCHEDULE V25
*          *          *26
D.  Depressants. Unless specifically exempted or excluded or unless listed27
in another schedule, any material, compound, mixture, or preparation which contains28 HLS 10RS-733	ENGROSSED
HB NO. 121
Page 5 of 5
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
any quantity of the following substances having a depressant effect on the central1
nervous system, including its salts:2
*          *          *3
(2)  Lacosamide4
*          *          *5
Section 2.  R.S. 40:964(Schedule IV)(B)(52) is hereby repealed in its entirety.6
DIGEST
The digest printed below was prepared by House Legislative Services. It constitutes no part
of the legislative instrument. The keyword, one-liner, abstract, and digest do not constitute
part of the law or proof or indicia of legislative intent.  [R.S. 1:13(B) and 24:177(E)]
Mills	HB No. 121
Abstract: Adds certain drugs to Schedules I, II, III, IV, and V of the Uniform Controlled
Dangerous Substances Law.
Present law provides for classification of controlled dangerous substances in Schedules I
through V.
Proposed law retains the provisions of present law and adds the following to Schedule I: 
Alphamethyltryptamine; 5-methoxy-N, N-diisopropyltryptamine; 2-[(1R,3S)-3-
hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol {also known as CP 47,497 and its C6,
C7, C8, and C9 homologues}; (6aR,10aR)-9-(hydroxyme	thyl)-6,6-dimethyl-3-(2-
methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo [c]chromen-1-ol {also known as HU-210};
Naphthalen-1-yl-(1-pentylindol-3-yl)methanone {also known as 1-Pentyl-3-(1-
naphthoyl)indole or JWH-018}; and Naphthalen-1-yl-(1-butylindol-3-yl)methanone {also
known as 1-Butyl-3-(1-naphthoyl)indole or JWH-073}.
Proposed law adds Oripavine, Tapentadol, and Lisdexamfetamine to Schedule II.
Proposed law adds Boldione, Desoxymethyltestosterone, and 19-nor-4, 9(10)-
androstadienedione to Schedule III.
Proposed law adds Fospropofol to Schedule IV and renumbers Carisprodol in Schedule IV.
Proposed law adds Lacosamide to Schedule V.
(Amends R.S. 40:964(Schedule III)(E)(9); Adds R.S. 40:964(Schedule I)(C)(13.1), (16.1),
(32), (33), (34), and (35), (Schedule II)(A)(1)(s), (B)(28), and (C)(7), (Schedule
III)(E)(12.1), (15.1), and (44.1), (Schedule IV)(B)(4.1) and (22.1), and (Schedule V)(D)(2);
Repeals R.S. 40:964(Schedule IV)(B)(52))